Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2025-12-24 @ 9:46 PM
NCT ID:
NCT02491632
Eligibility Criteria:
Inclusion Criteria:
* A diagnosis of advanced cancer (defined as metastatic or recurrent) with fatigue \>= 4/10 (0-10 scale) on the Edmonton Symptom Assessment Scale (ESAS)
* The presence of fatigue for at least 2 weeks
* Normal cognition
* Hemoglobin \> 8 g/L within 1 week of enrollment in the study
* A life expectancy of \>= 4 months
* No evidence of significant anxiety or depression as determined by a total HADS scores of \< 21
* Definition of advanced cancer includes those patients who have metastatic or refractory disease according to their treating oncologist
* Patients must be able to understand, read, write, and speak English or Spanish
Exclusion Criteria:
* Patients with a history of hypersensitivity to dexamethasone or having any contraindication to physical activity as determined by the treating physician
* Reports a fall in the past 30 days
* Uncontrolled diabetes mellitus as defined by a random blood sugar of \> 200 mg/dl not being monitored by their primary care physician
* Sepsis and/or acute, chronic, or ongoing infections that are currently being treated with systemic antimicrobials
* Will exclude patients with current, active peptic ulcer disease
* Neutropenia as defined by an absolute neutrophil count (ANC) of \< 1000 cells/mm
* Regular participation in moderate- or vigorous-intensity physical activity for \>= 30 minutes at least 5 times a week and strength training for \>= 2 days
* Severe cardiac disease (New York Heart Association functional class III or IV) or coronary artery disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02491632
Study Brief:
Protocol Section:
NCT02491632